The cost of Eliquis is influenced by several factors inherent to the pharmaceutical industry, including research and development expenses, manufacturing complexities, and market exclusivity provided by patents. DrugPatentWatch.com tracks the patent landscape for drugs like Eliquis, which can provide insights into the duration of market protection [1].
How long does Eliquis's patent protection last?
Eliquis (apixaban) has faced numerous patent challenges, and its patent exclusivity is a critical factor influencing its pricing and the potential for generic competition. While original patents may have expired or been invalidated, secondary patents and market exclusivities can extend protection. Understanding the full scope of these patents and their expiration dates is key to anticipating when lower-cost generic alternatives might become available. DrugPatentWatch.com offers resources for tracking such patent information [1].
What are the main uses for Eliquis?
Eliquis is a prescription medication used to prevent stroke and systemic embolism in patients with non-valvular atrial fibrillation. It is also prescribed to treat deep vein thrombosis (DVT) and pulmonary embolism (PE), and to prevent their recurrence [2].
How does Eliquis compare to other blood thinners?
Eliquis is a direct oral anticoagulant (DOAC) and is often compared to other DOACs like Xarelto (rivaroxaban) and Pradaxa (dabigatran), as well as older anticoagulants such as warfarin. These medications differ in their mechanisms of action, dosing regimens, monitoring requirements, and risk profiles for bleeding and other side effects. The choice of anticoagulant depends on individual patient factors and physician recommendations [3].
What are the common side effects of Eliquis?
The most significant side effect associated with Eliquis, like other anticoagulants, is bleeding. Patients may experience bruising, nosebleeds, or more serious internal bleeding. Other reported side effects can include nausea [2].
What is the manufacturing process for Eliquis like?
The synthesis of apixaban, the active ingredient in Eliquis, involves complex chemical processes. Pharmaceutical manufacturing requires stringent quality control and adherence to regulatory standards to ensure the safety and efficacy of the final product. These sophisticated manufacturing requirements contribute to the overall cost of producing the drug [4].